Neutral.
From Nasdaq: 2025-02-09 12:47:00 Disney (NYSE: DIS) released its fiscal first-quarter earnings, but the market responded with indifference as the
Category: Markets
Social Security faces significant funding shortfall, proposals to address include tax increases and benefit adjustments
From Nasdaq.: 2025-02-09 12:00:00 Social Security is facing a $23 trillion shortfall over the next 75 years, with trust funds
Investors should consider Vertex Pharmaceuticals and Moderna for long-term growth
From NASDAQ.: 2025-02-09 11:15:00 Equity markets had a strong January, but long-term investors should focus on companies with strong performance
Palantir Technologies stock has surged, showing impressive growth in financial results
From Nasdaq: 2025-02-09 10:30:00 Palantir Technologies (NASDAQ: PLTR) has seen a remarkable increase in its stock price, up 51% year
Guru fundamental report rates TSM highest with Peter Lynch's strategy
From Nasdaq: 2025-02-09 09:00:00 Validea’s guru fundamental report for TAIWAN SEMICONDUCTOR MFG. CO. LTD. (ADR) (TSM) shows that it rates
Summary: Meta Platforms stock has surged but faces challenges, with growth potential uncertain.
From Nasdaq: 2025-02-09 08:30:00 Meta Platforms (NASDAQ: META) has seen a massive surge in its stock price, growing by 490%
Vertex Pharmaceuticals expected to report 10.3% revenue growth and $4.02 per share earnings.
From StockStory.org: 2025-02-09 08:04:14 Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting its earnings tomorrow. Last quarter, the company beat
Edgewell Personal Care (EPC) is expected to report a revenue decline with missed estimates
From StockStory: 2025-02-09 08:03:49 Personal care company Edgewell Personal Care (NYSE:EPC) will be reporting earnings tomorrow before market open. Last
McDonald's will report earnings, analysts expect flat revenue and adjusted earnings growth
From StockStory: 2025-02-09 08:03:41 McDonald’s (NYSE:MCD) will report earnings tomorrow. Last quarter, the fast-food chain beat revenue expectations by 0.9%
Amkor (AMKR) is expected to report a 5% decline in revenue with adjusted earnings at $0.38 per share
From Barchart: 2025-02-09 08:03:25 Amkor Technology (NASDAQ:AMKR) is set to announce earnings results tomorrow after the bell. Last quarter, the
Simpson is expected to report a slight revenue decline in Q4.
From Barchart: 2025-02-09 08:02:48 Building products manufacturer Simpson (NYSE:SSD) is set to report earnings tomorrow after the market closes. Last
Hain Celestial expected to report $430.5 million revenue, down 5.2% with $0.12 EPS
From Stockstory.org – CNBC: 2025-02-09 08:02:37 Hain Celestial (NASDAQ:HAIN) is set to report earnings tomorrow. Last quarter, the company met
Incyte (INCY) expected to report revenue growth, but has historically missed revenue estimates
From Stock Story: 2025-02-09 08:02:10 Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) is set to report earnings tomorrow, with analysts expecting revenue
Rockwell Automation set to report earnings with expectations for revenue decline and missed revenue last quarter.
From Stock Story.: 2025-02-09 08:01:58 Rockwell Automation (NYSE:ROK) is set to report earnings, with analysts expecting a 7.8% revenue decline
Fluence Energy expected to report a 3.8% revenue growth with -$0.22 adjusted loss per share.
From StockStory: 2025-02-09 08:01:56 Fluence Energy is set to report earnings tomorrow after market hours. Last quarter, the company missed
Nvidia reports record-breaking revenue and stock split, CEO optimistic about future growth and innovation
From Barchart: 2025-02-09 08:00:02 Nvidia reported a record-breaking revenue of $6.51 billion in the third quarter, exceeding expectations by 8%.
Palantir Technologies stock surpasses $100 after solid Q4 earnings, analysts divided on further investment
From Nasdaq: 2025-02-09 07:30:00 Palantir Technologies’ (NASDAQ: PLTR) stock price soared past $100 after strong Q4 earnings highlighted its momentum
Invest in Vanguard Index ETFs for steady returns and low expenses
From Nasdaq: 2025-02-09 06:37:00 Investing in individual stocks can be risky, with 40% of stocks in the Russell 3000 index
XRP is designed for cross-border payments with low fees, while Bitcoin is inflation-resistant.
From Nasdaq: 2025-02-09 05:30:00 XRP and Bitcoin are both strong cryptocurrencies, but they differ in value and performance. XRP is
Investors can potentially turn $50,000 into $1 million by investing in Nasdaq-100, but risks remain.
From Nasdaq: 2025-02-09 05:06:00 Investors looking for growth stocks can turn to the Nasdaq exchange, with the exclusive Nasdaq-100 index
Investors can potentially become millionaires by investing in iShares Bitcoin Trust
From Nasdaq: 2025-02-09 04:05:00 Bitcoin has seen a massive 956% increase in the past five years, outperforming major stock indexes.
Market may have mispriced inflation odds, predicting disinflationary wave with potential Fed rate cuts
From Investing.com: 2025-02-09 02:28:00 The main macro thesis for the first half of 2025 predicts another disinflationary wave hitting the
4D Molecular Therapeutics sees reduction in injection burden for treating wet AMD
From Nasdaq: 2025-02-08 23:59:20 4D Molecular Therapeutics (FDMT) shared positive interim data from the Phase 2b PRISM trial, showcasing the
Regeneron's EYLEA HD shows positive Phase 3 results for retinal vein occlusion treatment
From Nasdaq: 2025-02-08 23:36:47 Regeneron Pharmaceuticals Inc. announced positive results from the Phase 3 QUASAR trial, testing EYLEA HD for
Positive: Regeneron's EYLEA HD shows sustained vision gains in wet AMD patients at 3 years.
From NASDAQ.: 2025-02-08 23:17:46 Regeneron Pharmaceuticals announced positive three-year results for EYLEA HD in patients with wet age-related macular degeneration.